Healthcare ❯ Clinical Trials
Amyloid Beta Bone Density Loss Side Effects Pharmacovigilance Systems
The Lancet Global Health paper offers the first large-scale LMIC evidence for a digital pharmacovigilance tool that is spurring calls for scale-up.
